People / Staff

Sandra Perez-Torras

Search publications

Publications

  • Camarero-Hoyos C, Bouzón-Arnáiz I, Avalos-Padilla Y, Fallica AN, Román-Álamo L, Ramírez M, Portabella E, Cuspinera O, Currea-Ayala D, Orozco-Quer M, Ribera M, Siden-Kiamos I, Spanos L, Iglesias V, Crespo B, Viera S, Andreu D, Sulleiro E, Zarzuela F, Urtasun N, Perez-Torras S, Pastor-Anglada M, Arce EM, Muñoz-Torrero D and Fernàndez-Busquets X.

    Leveraging the Aggregated Protein Dye YAT2150 for Malaria Chemotherapy

    Pharmaceutics . 16(10): . Number of citations: 1

    [doi:10.3390/pharmaceutics16101290]

  • Mata A, Vila-Planas A, Solsona-Pujol A, Dueña J, Torrents M, Izquierdo-García E, Pastor-Anglada M, Perez-Torras S and Terrazas M.

    RNase H-sensitive multifunctional ASO-based constructs as promising tools for the treatment of multifactorial complex pathologies.

    BIOORGANIC CHEMISTRY . 150: 107595-107595. Number of citations: 2

    [doi:10.1016/j.bioorg.2024.107595]

  • Pena-Rodriguez, E, García-Vega L, Lajarin Reinares M, Pastor-Anglada M, Perez-Torras S and Fernandez-Campos, F.

    Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation

    MOLECULAR PHARMACEUTICS . 20(5): 2317-2325. Number of citations: 3

    [doi:10.1021/acs.molpharmaceut.2c00796]

  • Pastor-Anglada M, Mata A and Perez-Torras S.

    Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (SLC28 and SLC29)

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 23(15): 8770. Number of citations: 7

    [doi:10.3390/ijms23158770]

  • Boces-Pascual, C, Mata A, Martin-Satue, M, Boix, L, Gironella, M, Pastor-Anglada M and Perez-Torras S.

    OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1

    CELLULAR AND MOLECULAR LIFE SCIENCES . 78(23): 7505-7518. Number of citations: 4

    [doi:10.1007/s00018-021-03959-8]

  • Pena-Rodríguez E, Lajarin-Reinares M, Mata-Ventosa A, Perez-Torras S and Fernández-Campos F.

    Dexamethasone-Loaded Lipomers: Development, Characterization, and Skin Biodistribution Studies.

    Pharmaceutics . 13(4): 533. Number of citations: 10

    [doi:10.3390/pharmaceutics13040533]

  • Perello C, Català-Temprano A, Caviedes L, Vega-García N, Camós-Guijosa M, Perez-Torras S and Pastor-Anglada M.

    FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia

    PHARMACOLOGICAL RESEARCH . 151: 104556-104556. Number of citations: 6

    [doi:10.1016/j.phrs.2019.104556]

  • Perez-Torras S, Mata-Ventosa A, Drögemöller B, Tarailo-Graovac M, Meijer J, Meinsma R, van Cruchten AG, Kulik W, Viel-Oliva A, Bidon-Chanal A, Ross CJ, Wassermann WW, van Karnebeek CDM, Pastor-Anglada M and van Kuilenburg ABP.

    Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE . 1865(6): 1182-1191. Number of citations: 7

    [doi:10.1016/j.bbadis.2019.01.013]

  • Pastor-Anglada M, Urtasun N and Perez-Torras S.

    Intestinal Nucleoside Transporters: Function, Expression, and Regulation.

    COMPREHENSIVE PHYSIOLOGY . 8(3): 1003-1017. Number of citations: 38

    [doi:10.1002/cphy.c170039]

  • Pastor-Anglada M and Perez-Torras S.

    Who Is Who in Adenosine Transport.

    FRONTIERS IN PHARMACOLOGY . 9: 627-627. Number of citations: 95

    [doi:10.3389/fphar.2018.00627]